News | December 06, 2023
Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The new ECO grade is made using renewable feedstock
Subscribe To Our Newsletter & Stay Updated
